X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rheumatology (17) 17
humans (16) 16
rheumatoid arthritis (13) 13
index medicus (12) 12
middle aged (11) 11
arthritis, rheumatoid - drug therapy (10) 10
female (10) 10
male (10) 10
treatment outcome (9) 9
adult (8) 8
aged (7) 7
double-blind method (7) 7
drug therapy (6) 6
time factors (6) 6
abatacept (5) 5
arthritis (5) 5
arthritis, rheumatoid - diagnosis (5) 5
clinical trials (5) 5
double-blind (5) 5
drug administration schedule (5) 5
efficacy (5) 5
internal medicine (5) 5
safety (5) 5
abridged index medicus (4) 4
clinical medicine (4) 4
immunosuppressive agents - administration & dosage (4) 4
methotrexate (4) 4
modifying antirheumatic drugs (4) 4
quality of life (4) 4
rheumatoid factor (4) 4
abatacept - administration & dosage (3) 3
american-college (3) 3
antirheumatic agents - administration & dosage (3) 3
antirheumatic agents - adverse effects (3) 3
antirheumatic agents - therapeutic use (3) 3
arthritis, rheumatoid - immunology (3) 3
arthritis, rheumatoid - physiopathology (3) 3
dose-response relationship, drug (3) 3
drug dosages (3) 3
infliximab (3) 3
medicine & public health (3) 3
medicine, general & internal (3) 3
severity of illness index (3) 3
adalimumab (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal - therapeutic use (2) 2
arthritis, rheumatoid - psychology (2) 2
arthritis, rheumatoid - therapy (2) 2
biologic (2) 2
biological products - administration & dosage (2) 2
biosimilar (2) 2
care and treatment (2) 2
circadian-rhythms (2) 2
cohort studies (2) 2
criteria (2) 2
development and progression (2) 2
disease-activity (2) 2
dosage and administration (2) 2
etanercept (2) 2
glucocorticoids - therapeutic use (2) 2
health aspects (2) 2
immunosuppressive agents - adverse effects (2) 2
inflammation (2) 2
interleukin-6 (2) 2
management (2) 2
monoclonal antibodies (2) 2
monoclonal-antibody (2) 2
patient outcomes (2) 2
patient-reported outcomes (2) 2
patients (2) 2
phase-iii (2) 2
quality-of-life (2) 2
receiving concomitant methotrexate (2) 2
recommendations (2) 2
reproducibility of results (2) 2
research article (2) 2
studies (2) 2
synovial-fluid (2) 2
therapy (2) 2
tnf inhibitors (2) 2
validation (2) 2
1506 (1) 1
162774-06-3 (1) 1
[ sdv.mhep.rsoa ] life sciences [q-bio]/human health and pathology/rhumatology and musculoskeletal system (1) 1
[sdv.mhep.rsoa]life sciences [q-bio]/human health and pathology/rhumatology and musculoskeletal system (1) 1
abatacept - adverse effects (1) 1
abatacept - immunology (1) 1
abatacept - therapeutic use (1) 1
activity index (1) 1
activity score (1) 1
acute coronary syndromes (1) 1
acute-phase reactants (1) 1
adalimumab plus methotrexate (1) 1
adjustment (1) 1
administration, intravenous (1) 1
administration, oral (1) 1
adolescent (1) 1
adverse event reporting (1) 1
agents (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 05/2007, Volume 66, Issue 5, pp. 628 - 632
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 6/2019, Volume 38, Issue 6, pp. 1615 - 1626
There are limited data on therapy selection and switching in psoriatic arthritis (PsA). This 18 country, real-world study assessed use and switching of... 
Health-related quality of life | Treatment | Medicine & Public Health | Rheumatology | Work | TNFi | Psoriatic arthritis | Care and treatment | Arthritis | Demography | Immunomodulation | Patients | Disease control | Quality of life
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 12/2017, Volume 56, Issue 12, pp. 2170 - 2178
Objective. To investigate the efficacy and safety of lesinurad, a selective uric acid reabsorption inhibitor, in a 6 month, phase 3 clinical trial and... 
Lesinurad | Phase 3 trial | Gout | Serum urate | CRITERIA | TOPHACEOUS GOUT | HYPERURICEMIA | MANAGEMENT | gout | RISK | lesinurad | RHEUMATOLOGY | serum urate | ARTHRITIS | phase 3 trial | FEBUXOSTAT
Journal Article
Journal Article